Garrison Michael David

Garrison Michael David is listed in filings as EVP & Pres Med.Essntl&BioPharm at Becton, Dickinson and Company. This profile follows SEC Form 4 activity through Jun 25, 2026, including sale activity. Recent filings connect the profile to Becton, Dickinson and Company (BDX). The current snapshot covers public activity from Nov 29, 2024 to Jun 25, 2026. Reported amounts are shown as $160.2K to $633.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.